Glycaemic control and microvascular complication among patients with youth onset diabetes in India using differing types of insulin and methods of glucose monitoring

Diabetes Research and Clinical Practice
Sunita MiglaniNarayana Kochupillai

Abstract

We assessed whether insulin types and monitoring methods were relevant to glycaemic control, microvascular complications as well as costs of management in 208 patients with youth onset diabetes in India. The type of insulin and monitoring method used made no difference to the glycaemic and complication status. Cost considerations support bovine insulin use along with urine glucose monitoring as an appropriate approach to diabetes self care in developing countries.

References

Apr 1, 1979·Archives of Disease in Childhood·M L Williams, D C Savage
Nov 1, 1990·Diabetic Medicine : a Journal of the British Diabetic Association·G M LennonC J Bailey
Feb 10, 2000·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research GroupDavid M Nathan
Dec 29, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·S CosterR Swaminathan
Feb 24, 2001·Diabetes Care·UNKNOWN Scottish Study Group for the Care of the Young Diabetic
May 30, 2001·Diabetes Research and Clinical Practice·R GoswamiN K Maclaren
Aug 3, 2001·Diabetes Research and Clinical Practice·R GoswamiN Kochupillai

❮ Previous
Next ❯

Citations

Sep 1, 2011·International Health·Fiona TranMaria E Craig
Aug 22, 2008·Diabetes Technology & Therapeutics·M HimanshuPrasanna K M Kumar
Dec 3, 2014·Globalization and Health·Charles A K YesudianAlessandra Ferrario
Sep 11, 2007·Journal of Diabetes and Its Complications·Maria E CraigYeo Jing Ping
Jan 28, 2005·The Cochrane Database of Systematic Reviews·B Richter, G Neises

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.